People

Kevin M. Yurkerwich, PhD

Senior Associate

Yurkerwich_Kevin

Kevin Yurkerwich is a senior associate who focuses his practice on complex intellectual property disputes. Mr. Yurkerwich represents clients before the US Patent and Trademark Office, in district courts and at the Federal Circuit. He has represented clients in patent disputes involving a broad range of technological fields, including pharmaceuticals, medical devices, tablet computers and diagnostic technologies. Mr. Yurkerwich maintains an active pro bono practice with an emphasis on helping eligible legal permanent residents overcome barriers to becoming US citizens.

Prior to joining the firm, Mr. Yurkerwich clerked for the Honorable Paul S. Grewal of the US District Court for the Northern District of California. During law school, Mr. Yurkerwich was a summer associate in the IP Litigation Practice in WilmerHale's Palo Alto office and in the Silicon Valley office of another major law firm. He was also a summer law clerk at the Habeas Corpus Resource Center in San Francisco, a state organization that provides legal representation for indigent petitioners in death penalty habeas corpus proceedings before the Supreme Court of California and the federal courts.

While obtaining his doctorate in chemistry at Columbia University, Mr. Yurkerwich worked with Professor Ged Parkin. At Columbia, Mr. Yurkerwich developed synthetic pathways to subvalent gallium and indium compounds and conducted extensive research related to mercury remediation. As an undergraduate at the Massachusetts Institute of Technology, Mr. Yurkerwich worked with Professor Kit Cummins and explored molybdenum-based alkyne metathesis precursors.

Representative Cases

  • Representation of pharmaceutical company in a multi-defendant, multi-patent ANDA litigation in District of New Jersey
  • Representation of pharmaceutical company in a multi-defendant, multi-patent ANDA litigation in the District of Delaware
  • Representation of pharmaceutical company in a multi-patent litigation in the District of New Jersey
  • Representation of medical device company in defending a patent infringement case involving surgical ablation devices
  • Representation of pharmaceutical company in an inter partes review proceeding before the Patent Trial and Appeal Board
  • Representation of molecular diagnostics company in inter partes review proceedings before the Patent Trial and Appeal Board

Publications & News

View

November 6, 2017

Increasing Role of Objective Indicia of Nonobviousness in AIA Proceedings

In this article published by Bloomberg Law's Patent, Trademark & Copyright Journal, authors Keith Slenkovich and Kevin Yurkerwich direct practitioners to carefully develop objective indicia evidence, and responses challenging the sufficiency of such evidence.

January 20, 2017

Practice Tips for Presenting and Responding to Motivation-to-Combine Arguments in IPR Proceedings

David Cavanaugh, Joshua Stern and Kevin Yurkerwich, in this article published by Bloomberg BNA's Patent, Trademark & Copyright Journal, provide an overview of recent PTAB decisions denying institution of inter partes review and share practice tips for practitioners to follow.

May 16, 2016

Congress Creates Federal Right of Action for Trade Secret Misappropriation

On May 11, President Obama signed into law the Defend Trade Secrets Act of 2016, which enables companies to go to federal court to sue for misappropriation of trade secrets.

Practices

Skip Navigation Links.

Education

JD, Stanford Law School, 2013, Stanford Journal of Law, Science & Policy

PhD, Chemistry, Columbia University, 2010

MPhil, Chemistry, Columbia University, 2009

MA, Chemistry, Columbia University, 2007

SB, Chemistry, Massachusetts Institute of Technology, 2005

Bar Admissions

California

Massachusetts

United States Patent and Trademark Office

Clerkships

The Hon. Paul S. Grewal, US District Court for the Northern District of California, 2013 - 2014

Skip Navigation Links.